MedTrace Logo

Pro-thrombotic Status in Patients with SARS-Cov-2 Infection

NCT04343053 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 145

Last updated 2024-12-12

No results posted yet for this study

Summary

The present study is ideated to prospectively investigate in patients with severe acute respiratory syndrome (SARS) due to Coronavirus 19 (SARS-Cov-2) infection and moderate-severe respiratory failure the patterns and changes in platelet reactivity, thrombotic status and endothelial function. The observed patterns and changes will be related with inflammatory status, myocardial injury and outcomes

Conditions

  • Severe Acute Respiratory Syndrome Coronavirus 2

Interventions

OTHER

SARS-Cov-2 infection

blood sample withdrawal

Sponsors & Collaborators

  • University Hospital of Ferrara

    lead OTHER

Principal Investigators

  • Savino Spadaro, MD · Intensive care unit

  • Gianluca Campo, MD · Cardiology Unit

  • Marco Contoli, MD · Pulmonology Unit

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-08
Primary Completion
2023-11-12
Completion
2024-12-07

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04343053 on ClinicalTrials.gov